Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 22, 2010
Determinants of variability in clearance of exogenous compounds in neonatesK Allegaert, J N Van Den Anker, C Tayman, et al.Medical Hypotheses|December 4, 2015
Possible effects of repeated exposure to ibuprofen and acetaminophen on the intestinal immune response in young infantsJ-P Langhendries, K Allegaert, J N Van Den Anker, et al.Acta Paediatrica (Oslo, Norway : 1992)|December 1, 1996
Pharmacokinetics and renal function in preterm infantsJ N van den AnkerInternational Journal of Clinical Practice. Supplement|November 21, 2012
Optimising the management of fever and pain in childrenJ N van den AnkerCurrent Pharmaceutical Design|September 28, 2017
Therapeutic Drug Monitoring in Neonates: What Makes them Unique?P Mian, R B Flint, D Tibboel, et al.Acta Clinica Belgica|April 5, 2008
Developmental pharmacology: neonates are not just small adultsK Allegaert, R Verbesselt, G Naulaers, et al.International Journal of Clinical Pharmacology and Therapeutics|September 12, 2006
Maturational changes in the in vivo activity of CYP3A4 in the first months of lifeK Allegaert, J N Van den Anker, A Debeer, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|July 1, 1993
Bleeding as presenting symptom of cholestasisJ N van den Anker, M SinaasappelBritish Journal of Anaesthesia|June 14, 2005
Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activityK Allegaert, B J Anderson, R Verbesselt, et al.Clinical Pharmacokinetics|April 1, 1995
Meropenem clinical pharmacokineticsJ W Mouton, J N van den AnkerPageof 13